XML 35 R22.htm IDEA: XBRL DOCUMENT v3.24.0.1
Net Income/(Loss) Per Share
 12 Months Ended
Dec. 31, 2023
Net Income/(Loss) Per Share [Abstract]  
NET INCOME/(LOSS) PER SHARE

13. NET INCOME/(LOSS) PER SHARE

 

The Company computes basic income/(loss) per share using net income/(loss) attributable to Vicarious Surgical Inc. common stockholders and the weighted-average number of common shares outstanding during each period. Diluted loss per share includes shares issuable upon exercise of outstanding stock options and stock-based awards where the conversion of such instruments would be dilutive.

 

   For the Years Ended
December 31,		 
   2023   2022 
Numerator for basic and diluted net income/(loss) per share:        
Net income/(loss)  $(71,071)  $5,157 
           
Denominator for basic net income/(loss) per share:          
Weighted average shares   146,006,388    121,791,878 
           
Denominator for diluted net income/(loss) per share:          
Weighted average shares   146,006,388    127,528,509 
           
Net income/(loss) per share of Class A and Class B common stock – basic and diluted
  $(0.49)  $0.04 

 

For the year ended December 31, 2023, 45,553,472 shares of the Company’s common stock were excluded from the calculation of diluted earnings per share because the exercise prices of the stock options and warrants were greater than or equal to the average price of the common shares and were therefore anti-dilutive.